2024
DOI: 10.1021/acs.jproteome.4c00248
|View full text |Cite
|
Sign up to set email alerts
|

The Future of Proteomics is Up in the Air: Can Ion Mobility Replace Liquid Chromatography for High Throughput Proteomics?

Yuming Jiang,
Daniel DeBord,
Heidi Vitrac
et al.

Abstract: The coevolution of liquid chromatography (LC) with mass spectrometry (MS) has shaped contemporary proteomics. LC hyphenated to MS now enables quantification of more than 10,000 proteins in a single injection, a number that likely represents most proteins in specific human cells or tissues. Separations by ion mobility spectrometry (IMS) have recently emerged to complement LC and further improve the depth of proteomics. Given the theoretical advantages in speed and robustness of IMS in comparison to LC, we envis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 86 publications
0
2
0
Order By: Relevance
“…Nevertheless, opportunities exist to refine DISPA to enable faster and deeper analysis of low-abundance biomarkers in plasma and other fluids, including cerebrospinal fluid (CSF), urine, and serum. This enhancement can be achieved through advances in the following dimensions, as we discussed more extensively in our recent perspective article Instrumentation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, opportunities exist to refine DISPA to enable faster and deeper analysis of low-abundance biomarkers in plasma and other fluids, including cerebrospinal fluid (CSF), urine, and serum. This enhancement can be achieved through advances in the following dimensions, as we discussed more extensively in our recent perspective article Instrumentation.…”
Section: Discussionmentioning
confidence: 99%
“…Second, currently, DISPA only uses Orbitrap mass analyzers. Faster mass spectrometers, such as the newly launched Astral, could allow us to significantly increase the scanning speed (up to ∼200 Hz), enabling us to target more biomarkers. , One challenge with new equipment is the need to develop software to manage new types of data. A third route to improving our approach with hardware advances is through increasing ionization efficiency, which can also enhance the depth of DISPA analysis.…”
Section: Discussionmentioning
confidence: 99%